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Abstract
Background: Using computational database searches, we have demonstrated previously that no
gene sequences could be found for at least 36% of enzyme activities that have been assigned an
Enzyme Commission number. Here we present a follow-up literature-based survey involving a
statistically significant sample of such "orphan" activities. The survey was intended to determine
whether sequences for these enzyme activities are truly unknown, or whether these sequences are
absent from the public sequence databases but can be found in the literature.
Results: We demonstrate that for ~80% of sampled orphans, the absence of sequence data is bona
fide. Our analyses further substantiate the notion that many of these enzyme activities play
biologically important roles.
Conclusion: This survey points toward significant scientific cost of having such a large fraction of
characterized enzyme activities disconnected from sequence data. It also suggests that a larger
effort, beginning with a comprehensive survey of all putative orphan activities, would resolve nearly
300 artifactual orphans and reconnect a wealth of enzyme research with modern genomics. For
these reasons, we propose that a systematic effort to identify the cognate genes of orphan enzymes
be undertaken.
Background
After a decade of comprehensive genomic sequencing,
more than 500 genomes have been sequenced to comple-
tion, mostly prokaryotes. The prodigious rate of new
sequence annotation is highlighted by the fact that there
were just over 300 genomes available when this study was
carried out in late 2004. However, the fraction of genes for
which no function can be predicted remains high (30%–
50%). In response, proposals have been put forth for the
bioinformatics analysis of bacterial genomes to identify
genes with high likelihood of scoring true in confirmatory
laboratory assays of their respective function [1,2]. This
would increase the field's pool of experimentally charac-
terized proteins, with concomitant increases in the accu-
racy and coverage of genome annotation. We believe the
return on investment of this approach would be particu-
larly high when addressing the problem of orphan activi-
ties, that is, enzymatic activities for which no sequence
information is available [3,4].
Decades of detailed enzymology have created a wealth of
knowledge about enzymes and their activities. However,
crucial aspects of these enzymes are absent from bioinfor-
matics databases with surprising frequency. For example,
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recent computational analyses of sequence databases
demonstrate that at least 36% of enzyme activities that
have been assigned an Enzyme Commission (EC) number
[5] appear to be devoid of a gene or protein sequence [3].
Since then, similar analyses have been published, with
similar results [4,6,7]. The existence of such a large frac-
tion of orphan activities is surprising, given that many of
these enzymes have been described decades ago and are
often involved in basic cellular functions. Several exam-
ples exist of the recent identification of genes involved in
important enzymatic functions (reviewed in [1,2]).
Indeed, in our study 44 orphans were found to be present
in one or more primary metabolic pathways in a variety of
species (described below). Details of many of the orphan
enzymes uncovered during this survey point to multiple
and significant consequences for the lack of sequence
information in areas such as genome annotation, compu-
tational pathway prediction, and metabolic engineering.
For these reasons, the orphan problem and related issues
were highlighted in a recent report of the American Soci-
ety for Microbiology [8]. In view of the biological richness
associated with orphan enzymatic activities (Figure 1,
Table 1), we have taken the first steps in creating the foun-
dations of an Enzyme Genomics Initiative [3].
Here we describe a literature-based survey of presumed
orphans intended to further validate and characterize
these activities (Figure 2). The confidence of the results of
this survey was designed to be within a 5% error margin
relative to the universe of orphan activities, based on a
randomly selected subset of orphan activities from the
Nomenclature Committee of the IUBMB (NC-IUBMB).
We have also assessed the practicability of identifying the
genes associated with these orphans. As a consequence,
the survey captures data from the literature that should
facilitate the identification of cognate genes for the
orphan activities evaluated. Here, we define the cognate
gene for an activity as a gene that has been shown to code
for an enzyme that carries out that activity.
The survey confirmed that ~80% of the sampled orphans
do not have sequence information associated with them.
Consequently, this lack represents a true information def-
icit. Weaknesses in database integration and a lack of
information capture from the literature to databases
appear to be largely responsible for most of the artifactual
orphans making up the other 20%. Given the importance
of these enzymatic activities, we propose that the public
sequence databases assign high priority to correcting data-
base entries for artifactual orphans. We further propose
that a systematic effort be undertaken to sequence the
genes of validated orphans, as this survey demonstrates
that primary literature data and database analyses com-
bined with current proteomics and genomic technologies
should be adequate to enable the rapid identification of
many of these genes.
Results
Most orphan enzymatic activities are bona fide (Table 2).
Our survey found that more than 80% of orphans are not
due to artifacts such as missing database annotations (pri-
marily failure to capture information from the literature),
or lack of database cross-referencing, such as the availabil-
ity of a sequence in one database not being reflected in a
second database. Specifically, a total of 187 orphans out
of 228 surveyed activities were validated in at least one of
287 species (species are listed in Table 3 and Table 4, the
list of validated orphans is in Table 5). A majority of
orphans (54.36%) occurred in Eukaryotes, followed by
Eubacteria (39.37%) (Table 6). Within the Eubacteria,
genus  Pseudomonas  was significantly overrepresented
(35%) (Table 7). While a systematic determination of the
species spectrum of orphan activities was not performed
here, we did notice several cases of an orphan activity
reported in more than one species, as well as one case of
an orphan activity occurring in species from different
domains.
Because the eventual isolation of the cognate genes of
these activities is greatly facilitated by comprehensive
genome sequencing, we determined for what fraction of
all validated orphans a full genome sequence is available
(Table 8). 43% of Eubacterial species in which orphans
occurred were found to have such sequences, available
either presently or due shortly. This figure rises to 83%
when including the genomes of related species, on the
assumption that they might be sufficiently closely related
to permit the identification of the cognate gene. For exam-
ple, at the time of this study the completed genome
sequence of Pseudomonas fluorescens was not available,
but those of three other Pseudomonas species were.
Oxidoreductases (EC1) and transferases (EC2) were the
most frequently represented classes of enzymatic activity
for validated orphans (Figure 3). On a per capita basis,
oxidoreductases and transferases were overrepresented by
~20%, whereas hydrolases and ligases were underrepre-
sented by 35% and 64%, respectively.
The original publication date for all orphans was broadly
distributed around a mean of 1977 (Figure 4), compared
to a mean of 1975 for validated orphans.
Causes of artifacts
A comprehensive list of artifactual orphans and the
inferred nature of the artifact is available [9]. Although
this study was not designed to determine conclusively the
causes of artifactuality, incompleteness in database entries
appears to be the predominant cause of the artifacts iden-BMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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tified here. For example, the DNA sequence associated
with reaction 3.5.1.79 is available in the EMBL database,
however, the UniProt entry for this enzyme does not list
any protein sequence (Table 9). Other representative arti-
factual orphans are listed in Table 9, along with a descrip-
tion of the cause of the artifact. In a small fraction of cases
a clear determination of the species in which the activity
was characterized could not be made.
Extent of salvageability
Validated orphans were analyzed to determine whether
sufficient information is available from their published
characterization that, when combined with other factors,
could enable the rapid identification of at least one cog-
nate gene. Overall, we determined that 57 validated
orphans (25% of total) might be salvageable (Figure 5A;
Table 10), distributed approximately equally across
Example of a metabolic pathway involving a validated orphan Figure 1
Example of a metabolic pathway involving a validated orphan.BMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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Table 1: Biological significance of selected validated orphans. The extent and significance of published research associated with a 
selection of validated orphans is detailed
EC No. Activity Year first
published
No. PubMed
Publications Involving
Orphan
Significance
1.1.1.43 Phosphogluconate 2-
dehydrogenase
1961 2417 Positive reports of evaluation as a drug target against 
Trypanosome; trypanocidal activity has been reported; 
involved in 2-dehydro-D-gluconate degradation pathway
2.3.1.23 1-acylglycerophosphocholine O-
acyltransferase
1967 256 Activity is present in lower eukaryotes, plants, and multiple 
mammalian tissues
5.1.3.17 Heparosan-N-sulfate-
glucuronate 5-epimerase
1979 16 Involved in the biosynthesis of heparan sulfate, which binds 
proteins to modulate signaling events in embryogenesis. 
Mouse gene   knock-out results in late lethal phenotype.
Correction added in proof: Thanks to a comment by Dr. K. 
Robison and research by Dr. A. Shearer, we have found that 
5.1.3.17 is an   artifactual orphan rather than a validated 
orphan.  Genes for this enzyme have been identified in cow 
and mouse (J Biol Chem   272:28158 1997; J Biol Chem 
276:20069 2001).
2.3.1.105 Alkylglycerophosphate 2-O-
acetyltransferase
1986 9 Involved in platelet activating factor biosynthesis; possible 
involvement in ischemia
3.1.3.59 Alkylacetylglycerophosphatase 1986 9 Involved in platelet activation factor biosynthesis
2.7.1.106 Glucose-1,6-bisphosphate 
synthase
1975 9 Present in several mammalian tissues. Involved in glucose 
metabolism
1.2.1.23 2-oxoaldehyde dehydrogenase 
(NAD+)
1967 9 Involved in the development of diabetic complications
1.14.11.6 Thymine dioxygenase 1972 9 Present in both lower and higher eukaryotes
1.1.1.16 Galactitol 2-dehydrogenase 1956 5 Insulin dysregulation
2.3.1.14 Glutamine N-
phenylacetyltransferase
1957 4 Investigated as a predictor of carotid endarterectomy in 
middle-aged individuals
1.2.1.25 2-oxoisovalerate 
dehydrogenase (acylating)
1969 4 Present in prokaryotes and eukaryotes. In the latter, 
participates in primary metabolism pathway for valine 
degradation
E.C. 2.3.1.23 is listed in italics because it was cloned and sequenced in 2006, after the completion of this study
eukaryotes and bacteria. Far more bacterial orphans were
judged to have "excellent" or "good" salvageability as
compared with eukaryotic orphans: 70% (7+12 out of 27)
vs. 48% (5+11 out of 33), respectively (Figure 5B). This
discrepancy is primarily due to factors such as the much
greater difficulty for purifying an activity from higher
eukaryotes, the difficulty of obtaining enough starting
protein from lower eukaryotes such as multicellular fungi,
and the absence of a comprehensive genome sequence
from species such as Bos Taurus and Sus scrofa.
Overall, more than half of the salvageable orphans ranked
"good" or "excellent", with oxidoreductases (EC1) and
hydrolases (EC2) being overrepresented in that set. All
other enzymatic classes were significantly underrepre-
sented (Figure 6).
Discussion
This survey demonstrates that ~80% of orphan enzymatic
activities are bona fide; therefore, we conclude that of the
1,356 putative orphans extant at the time of this study,
more than 1,000 are highly likely to constitute true infor-
mation deficits since their lack of sequence information is
not the result of a database error.
The absence of DNA or protein sequences encoding such
well-characterized enzymatic activities is particularly con-
sequential because these activities were often identified
decades ago, and many have been the focus of significant
research activity (Table 1). Without the cognate sequences
for these activities, the quality of annotation of all
sequenced genomes in terms of both coverage (fraction of
genes that can be recognized) and accuracy (fraction of
predicted gene functions that are correct) is diminished.
Many of these activities may go for years without being
sequenced – for example, 1-acylglycerophosphocholine
O-acyltransferase (Table 1) was finally purified and
sequenced nearly forty years after it was first characterized
[10]. Perhaps more troubling is the unknown pool of
"false positive" annotations. Phosphogluconate 2-dehy-
drogenase (Table 1), an orphan at the time of this analy-
sis, has since been assigned to a sequence in the human
genome with no experimental evidence linking it to that
or any homologous sequence, but apparently instead onBMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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the basis of the gene in question already being assigned a
similar activity. This kind of "hidden orphan" would have
been missed by most orphan analyses, and can be
expected to propagate a potentially incorrect assignment
to other genomes in the future. Computational metabolic
pathway prediction [11] and metabolic engineering also
depend on sequence information and are thus similarly
compromised.
Conversely, ~20% of orphans surveyed were observed to
be artifacts, such that ~270 orphans out of 1,356 putative
orphans examined should be resolvable entirely via liter-
ature research and database cleanup. As a result of this
process as it was carried out on our sampling of orphans,
we have reported 11 artifactual orphan activities to public
sequence repositories for correction (see Table 8 for exam-
ples).
In addition to validating orphans, the survey was useful in
capturing information from the literature to assess their
salvageability: more than half of validated orphans were
found to be salvageable (Figure 5). Examples of salvagea-
ble orphan activities with the traits that make them sal-
vageable are listed in Table 11.
As abundantly noted elsewhere, such database cleansing
is essential to maximize the existing research investment
and prevent the propagation of mistakes [12-14] (see
Table 12 for examples of artifacts that have been
resolved). This necessity has not eluded the field of enzy-
Literature survey process Figure 2
Literature survey process.BMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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Table 2: Summary of survey results
Number Proportion
Total number of putative orphans 1,356
Number required to achieve 95% significance 180 13.3%
Number orphans evaluated 228 16.8%
Out of 228 orphans:
Number of artifactual orphans 41 18.0%
Number of valid orphans 187 82.0%
Max. number of salvageable orphans (all rankings) 57 25.0%
Out of 57 salvageable orphans: Number Proportion
Excellent 91 5 . 8 %
Good 23 40.4%
Marginal 91 5 . 8 %
Poor 16 28.1%
Bacterial salvageable orphans 26 45.6%
Eukaryotic salvageable orphans 31 54.4%
The survey was designed to achieve a maximum sampling error of 5%, 19 times out of 20. This corresponds to a minimum sample size of ~80 
orphans. A total of 228 orphans were in fact surveyed. In a number of cases more than one instance of an orphan activity was evaluated because the 
activity was reported in more than one species. Consequently, 286 instances were evaluated.
Table 3: Species distribution of Eubacterial validated orphans
Species No. of Orphans Species No. of Orphans
Acinetobacter NCIB 9871 1 Pasteurella tuberculosis 2
Actinoplanes missouriensis 1 Pedobacter heparinus 1
Aerom onas sp. 1 Propionibacterium pentosaceum 1
Alcaligenes eutrophus 1 Proteus mirabilis 1
Alcaligenes faecalis 1 Pseudomonas (species undefined) 2
Arthrobacter GJM -1 1 Pseudomonas fluorescens 3
Arthrobacter oxydans 1 Pseudomonas graveolens 1
Arthrobacter sp. 2 Pseudomonas MS 1
Azotobacter vinelandii 1 Pseudomonas MSU-1 1
Bacillus subtilis 1 Pseudomonas P-2 2
Cellulom onas sp. 1 Pseudomonas putida 7
Clostridium cylindrosporum 1 Pseudomonas putida P2 1
Clostridium kluyveri 2 Pseudomonas saccharophilia 2
Clostridium pasteurianum 1 Pseudomonas sp. 4
Clostridium SB4 1 Pseudomonas sp. P-501 1
Clostridium sporogenes 2 Pseudomonas syringae GG 1
Corynebacterium cyclohexanicum 1 Pseudomonas testosteroni 1
Escherichia coli 8 Rhodococcus 1
Flavobacterium 1 Rhodopseudomonas sphaeroides 1
Flavobacterium sp. 1 Salmonella typhimurium 1
Klebsiella aerogenes 1 Streptococcus faecalis 1
Micrococcus denitrificans 1 Streptococcus mutans 1
Microorganism 2 Streptomyces virginiae 1
Mycobacterium tuberculosis 1 Thiobacillus thioparus 1
Nocardia (species undefined) 1 Unknown 2
The total number of orphans is greater than the number of activities because a given activity may be present in more than one species. The exact 
species of some orphans can be unclear or unstated, in which case these are classified under a generic term ("species undefined", "unknown", etc). 
The total number of orphans is greater than the number of activities because a given activity may be present in more than one species. The exact 
species of some orphans can be unclear or unstated, in which case these are classified under a generic term ("species undefined", "unknown", etc).BMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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mology [3,4,15,16], and the present survey demonstrates
the usefulness of correlating biological databases and
mining the literature to enhance the value of existing
research and facilitate the identification of the remaining
orphan-associated genes. Until recently, there were no
general repositories of orphan activity data, although
some species-specific databases and pages were main-
tained, such as EchoBase [17] and a web page listing uni-
dentified  E. coli enzymes maintained by the EcoCyc
project [18]. Consequently, we updated the MetaCyc [19]
database to identify reactions that have been analyzed by
this survey, and annotated them and associated database
objects with results such as the validity of their orphan sta-
tus, links to their cognate protein in the case of artifacts,
and the properties of the protein copurifying with the
activity in the case of validated orphans. Recently,
Lespinet and Labedan created ORENZA [20], a database
dedicated to maintaining an up-to-date listing of all
enzyme activities for which no sequences are available in
major sequence databases [6]. We are contributing our
updated orphan information to ORENZA as well. These
data, captured in MetaCyc and ORENZA, should facilitate
the work of enzymologists interested in identifying the
cognate genes of orphan activities. For instance, the work
of Melnick et al. [21] is an excellent example of the com-
bined application of modern laboratory and bioinformat-
ics techniques that would benefit from the data described
here.
Several proposals have been made recently aimed at pro-
ducing a complete catalog of biochemical activities, bio-
logical functions, and their cognate genes [2,3]. Many of
these proposals recommend that such a project begin with
prokaryotes because of the general ease of gene cloning
Table 4: Species distribution of Eukaryotic validated orphans
Species No. of Orphans Organism No. of Orphans
Acrocylindrium sp. 1 Nectria haem atococca/Fusarium solani f.sp. Phaseoli 1
Arachis hypogaea 2 Neurospora (subspecies undefined) 1
ASparagus officinalis 1 Neurospora crassa 1
Aspergillus niger 2 Ochromonas malhamensis 1
Avena coleoptiles 1 Ovis aries 2
Bauhenia monandra 1 Pea sativum var. Alaska 1
Bostaurus 3 Penicillium atrovenetum 1
Capra hircus 1 Penicillium chrysogenum 1
Catharanthus roseus 1 Penicillium patulum 1
Cavia porcellus 3 Phaseolus aureus 3
Chlorella 1 Phaseolus radiatus 1
Chrysosplenium americanum 1 Pisum sativum (variety unspecified) 1
Cichorium endivia 1 Pycnoporus coccineus 1
Citrus (subspecies undefined) 1 Raphanus sativus 1
Corydalis cava 1 Rat (subspecies undefined) 18
Cucurbita maxima 1 Rat Sprague-Dawley 5
Daucus carota 1 Rhodotorula glutinis 2
Entamoeba histolytica 1 Saccharomyces cerevisiae 5
Euglena gracilis 1 Saccharum officinarum 1
Flaveria spp. 1 Secale cereale 1
Fundulus heteroclitus 1 Sesamum indicum 1
Gallus gallus 1 Several 1
Homo sapiens 5 Sorghum bicolor 2
Hordeum (species undefined) 1 Spinacia 1
Hordeum vulgare subsp. Vulgare 2 Spinacia oleracea 1
Lasallia pustulata 1 Sus scrofa 7
Lilium longiflorum 1 Tecoma stans 1
Lupinus albus 1 Thea sinensis 1
Lycopersicon esculentum 2 Trypanosoma brucei brucei 1
Macaca mulatta 1 Tulipa cv. Apeldoorn 1
Mentha piperita 1 Unknown 1
Mesocricetus auratus 1 Yeast (species undefined) 4
Mold 1 Zea mays 2
Mouse (species undefined) 3
The total number of orphans is greater than the number of activities because a given activity may be present in more than one species. The exact 
species of some orphans can be unclear or unstated, in which case these are classified under a generic term ("mold", "mouse", "unknown", etc). The 
total number of orphans is greater than the number of activities because a given activity may be present in more than one species. The exact species 
of some orphans can be unclear or unstated, in which case these are classified under a generic term ("mold", "mouse", "unknown", etc).BMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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Table 5: Validated orphan activities
EC No. Ranking EC No. Ranking EC No. Ranking
1.1.1.13 difficult 1.14.99.24 difficult 3.1.3.47 good
1.1.1.16 difficult 1.21.3.2 difficult 3.1.3.59 difficult
1.1.1.43 difficult 1.97.1.3 difficult 3.1.3.72 difficult
1.1.1.54 difficult 2.1.1.112 difficult 3.1.4.43 difficult
1.1.1.84 excellent 2.1.1.137 artifact 3.1.6.17 good
1.1.1.92 marginal 2.1.1.141 artifact 3.1.8.2 artifact
1.1.1.101 difficult 2.1.1.143 artifact 3.2.1.56 difficult
1.1.1.144 difficult 2.1.1.147 difficult 3.2.1.77 difficult
1.1.1.146 artifact 2.1.1.84 difficult 3.2.1.100 good
1.1.1.163 artifact 2.1.1.99 difficult 3.2.1.112 excellent
1.1.1.172 good 2.1.2.4 difficult 3.2.1.115 difficult
1.1.1.196 good 2.3.1.14 difficult 3.2.1.128 excellent
1.1.1.208 poor 2.3.1.23 difficult 3.2.1.136 difficult
1.1.1.226 excellent 2.3.1.24 artifact 3.2.1.137 poor
1.1.1.245 artifact 2.3.1.33 difficult 3.2.2.10 difficult
1.1.1.258 artifact 2.3.1.49 difficult 3.4.11.16 good
1.1.1.265 excellent 2.3.1.68 marginal 3.4.13.7 difficult
1.1.2.5 artifact 2.3.1.96 difficult 3.4.17.16 good
1.1.3.23 difficult 2.3.1.98 good 3.4.21.103 artifact
1.17.1.1 difficult 2.3.1.102 artifact 3.4.22.44 artifact
1.17.99.2 artifact 2.3.1.103 poor 3.4.22.46 artifact
1.2.1.18 artifact 2.3.1.105 poor 3.4.23.28 difficult
1.2.1.20 difficult 2.3.1.114 poor 3.4.23.30 artifact
1.2.1.23 poor 2.3.1.133 marginal 3.4.24.54 artifact
1.2.1.25 difficult 2.3.1.140 difficult 3.5.1.30 good
1.2.1.32 artifact 2.3.1.161 artifact 3.5.1.33 artifact
1.2.1.33 difficult 2.3.2.3 artifact 3.5.1.39 poor
1.2.1.52 difficult 2.3.2.7 difficult 3.5.1.58 excellent
1.2.1.54 good 2.3.3.3 difficult 3.5.1.62 artifact
1.2.1.63 marginal 2.4.1.23 poor 3.5.1.67 difficult
1.2.1.64 artifact 2.4.1.29 difficult 3.5.1.71 poor
1.2.3.6 difficult 2.4.1.41 valid 3.5.1.79 artifact
1.2.3.7 poor 2.4.1.43 difficult 3.5.2.13 poor
1.2.3.8 artifact 2.4.1.57 artifact 3.5.2.16 artifact
1.3.1.4 difficult 2.4.1.66 artifact 3.5.3.2 good
1.3.1.5 difficult 2.4.1.73 artifact 3.5.5.2 difficult
1.3.1.6 artifact 2.4.1.97 difficult 3.6.1.18 excellent
1.3.1.11 difficult 2.4.1.110 poor 3.6.1.2 artifact
1.3.1.37 difficult 2.4.1.125 difficult 3.6.1.52 artifact
1.3.7.1 difficult 2.4.1.126 valid 3.6.3.17 artifact
1.3.99.15 artifact 2.4.1.153 poor 3.6.3.24 artifact
1.3.99.21 artifact 2.4.1.167 difficult 3.6.3.28 artifact
1.4.1.11 good 2.4.1.176 difficult 3.6.4.4 artifact
1.4.1.17 good 2.4.1.180 excellent 4.1.1.24 difficult
1.4.99.4 marginal 2.4.1.184 difficult 4.1.1.52 difficult
1.4.99.5 artifact 2.4.1.215 artifact 4.1.1.56 difficult
1.5.1.21 good 2.4.2.35 difficult 4.1.1.75 difficult
1.5.99.11 artifact 2.5.1.4 difficult 4.1.2.23 difficult
1.6.5.7 artifact 2.5.1.42 difficult 4.1.2.28 difficult
1.7.3.1 difficult 2.6.1.22 difficult 4.1.2.35 difficult
1.7.3.5 valid 2.6.1.27 poor 4.1.3.35 difficult
1.8.1.5 artifact 2.6.1.32 difficult 4.2.1.5 difficult
1.10.1.1 difficult 2.6.1.33 poor 4.2.1.43 good
1.10.3.4 difficult 2.6.1.75 good 4.2.1.62 good
1.12.98.2 artifact 2.7.1.43 difficult 4.2.1.77 difficult
1.13.11.14 difficult 2.7.1.54 difficult 4.2.1.81 difficult
1.13.11.24 artifact 2.7.1.64 difficult 4.2.1.93 difficult
1.13.11.25 artifact 2.7.1.77 difficult 4.2.1.97 marginal
1.13.11.35 difficult 2.7.1.106 difficult 4.2.1.101 artifactBMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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from these species [1,2]. Indeed, our data support this
notion, as we find substantially more orphans with a sal-
vageability ranking of "good" and "excellent" in prokary-
otes as compared to eukaryotes. The availability of a
comprehensive review of the problem achieved by this
survey, combined with broad genomic sequencing and
powerful computational tools, leads us to conclude that
the field is in an excellent position to rectify the informa-
tion gap associated with the orphan activity phenome-
non.
Conclusion
More than one third of enzyme activities with assigned EC
numbers are orphan activities, having no associated gene
or protein sequence. We carried out a literature-based sur-
vey of a representative sample of presumed orphans
intended to further validate and characterize these orphan
activities. We have also assessed the practicability of iden-
tifying the genes associated with these orphans. In doing
so, we captured data from the literature that should assist
in future identification of cognate genes for the orphan
activities we examined.
This survey confirmed that about 80% of sampled orphan
activities have no sequence information associated with
them, either in databases or in the literature. Weaknesses
in database integration and failure to capture information
from the literature account for most of the remaining
20%.
This survey points toward the significant scientific cost of
having such a large fraction of characterized enzyme activ-
ities disconnected from sequence data. It also suggests
that a larger effort, beginning with a comprehensive sur-
vey of all putative orphan activities, would resolve nearly
300 artifactual orphans and reconnect a wealth of enzyme
research with modern genomics. For these reasons, we
propose that a systematic effort to identify the cognate
genes of orphan enzymes be undertaken.
Methods
Literature survey process
This survey was performed from June through August
2004 and relied on enzyme activities described by the NC-
IUBMB. This enzyme classification and nomenclature sys-
tem is hierarchical in nature and is based upon the reac-
tion catalyzed. It assigns specific numerical identifiers, an
Table 6: Domain distribution of validated orphans
Domain No. Species Proportion
Eukaryota 156 54.36%
Eubacteria 113 39.37%
Unknown 15 5.23%
Viruses 2 0.70%
Archaea 1 0.35%
Orphans with "Unknown" listed for their domain tend to be microbes that were insufficiently characterized to place them in either the Eubacteria 
or Archaea domains.
1.13.12.9 good 2.7.1.131 poor 4.2.2.14 artifact
1.14.11.10 difficult 2.7.1.134 difficult 4.2.3.19 artifact
1.14.11.6 poor 2.7.1.142 difficult 4.2.99.19 artifact
1.14.13.10 marginal 2.7.4.20 difficult 4.3.1.10 difficult
1.14.13.23 good 2.7.7.44 difficult 4.3.1.20 difficult
1.14.13.24 artifact 2.7.7.51 difficult 4.5.1.4 difficult
1.14.13.42 difficult 2.7.8.10 difficult 5.1.1.6 difficult
1.14.13.51 difficult 2.7.8.22 difficult 5.1.1.9 marginal
1.14.13.58 excellent 2.8.1.3 excellent 5.1.3.17 difficult
1.14.13.60 difficult 2.8.2.28 difficult 5.2.1.10 difficult
1.14.13.72 difficult 3.1.1.36 difficult 5.2.1.11 difficult
1.14.13.73 artifact 3.1.1.39 difficult 5.4.3.5 artifact
1.14.15.2 difficult 3.1.1.40 poor 5.5.1.11 good
1.14.16.5 good 3.1.1.78 artifact 5.5.1.12 artifact
1.14.99.18 artifact 3.1.2.11 difficult 5.5.1.3 difficult
1.14.99.22 artifact 3.1.3.14 difficult 6.3.1.6 difficult
3.1.3.38 poor 6.3.4.8 difficult
All 228 orphans reviewed in this study are listed. The salvageability of an orphan is ranked "difficult" when factors such as unclear species of origin, 
lack of molecular descriptors, or lack of comprehensive genome sequence hinder cloning of the cognate gene. Note that such rankings do not take 
into account the availability of molecular descriptors which enable the identification of a candidate gene in one species, and, through orthology, the 
identification of a candidate gene in a second species for which these descriptors are not available.
Table 5: Validated orphan activities (Continued)BMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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EC number, to each distinct enzymatic activity. The first
digit represents the class of reaction catalyzed (e.g., oxi-
doreductases are EC1; transferases are EC2). The second
digit of the EC number refers to the subclass, which gen-
erally contains information about the type of compound
or group involved (e.g., an enzyme acting on the CH-OH
group of donors, or acting on the aldehyde or oxo group
of donors). The third digit defines the sub-subclass, which
specifies the nature of the reaction. The fourth digit is a
serial number that is used to identify the individual
enzyme within a sub-subclass (see [22] for a description
of the classification system).
It is important to bear in mind that distinct proteins cata-
lyzing the same reaction are assigned the same EC
number. Since the EC system is based upon the reaction
catalyzed, when applied to a protein it describes a bio-
chemical function of this protein. That function can also
be shared by several proteins (isozymes) that can be
coded by genes in the same or different species.
Presumed orphan EC numbers were identified using the
BioWarehouse database system [23]. BioWarehouse [24]
is an integrated database that enables cross-database que-
ries using the structured query language (SQL). SRI's Bio-
Warehouse instance was queried for enzymatic activities
with no matching sequences in any major protein
sequence databases, including TrEMBL, PIR, SWISS-
PROT, CMR, ENZYME, and BioCyc (the selection of these
databases is described in [3]). This query returned an ini-
tial list of 1,356 EC numbers that had not been retired or
merged at the time of the survey.
This list was randomized and the primary literature asso-
ciated with a sample of these putative orphans was proc-
essed successively according to that random order. The
size of the sample necessary to ensure representational
accuracy as compared to the total pool of EC numbers was
calculated using Equation 1. Approximately 180 orphans
are required to achieve better than 95% confidence, given
the total number of EC numbers. Since a sample of 228
orphans was ultimately surveyed, the 95% level of signif-
icance was exceeded.
Equation 1: sample size estimation
SE is the standard error associated with the survey, and
is derived by dividing the sampling error by 1.96, such
that for a sampling error of 5% (95% confidence inter-
val), the standard error is 0.0255102. p is the probabil-
ity that the EC number is a true positive, that is, there
is truly no sequence information for that EC number;
this value is 0.85 based on data from a preliminary
survey. N is the universe of orphan activities. Solving
for n provides the sample size.
SE2 = [(p(1-p)/n)] [(N-n)/N]
A comprehensive manual analysis of the literature associ-
ated with this sample of 228 orphans drawn from the ran-
domized list was performed as outlined in Figure 2.
Various databases (Table 13) were consulted to extract the
data elements listed in Table 12. For each selected putative
orphan in the sample, the text search engine ExPASy Pro-
teomics Server [25] was used to search TrEMBL, ENZYME,
and IUBMB database records to confirm the absence of
sequence data. For each orphan, all protein names, author
names, reaction names, substrate names, and product
names listed in the IUBMB record for that orphan were
used as query arguments.
The primary literature associated with each orphan's entry
in the IUBMB database [5,26] describing the isolation and
Table 7: Top four most represented Eubacteria
Genus No. instances of orphans Fraction of all Eubacteria
Pseudomonas 27 35.06%
Escherichia 81 0 . 3 9 %
Clostridium 7 9.09%
Arthrobacter 4 5.19%
Table 8: Availability of completely sequenced genomes for Eubacterial validated orphans
Complete genome sequence Ongoing genome sequencing
Count Proportion Count Proportion
Same species 23 31.9% 9 18.4%
Same genus, related species 12 16.7% 16 32.6%
The number of available comprehensive genome sequences for validated Eubacterial orphans was tallied. Cases where the genome sequence of a 
species does not exist but where the sequence of a related species from the same genus is available are also listed, as are ongoing comprehensive 
genomic sequencing projects for genomes not currently available.BMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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characterization of the activity was reviewed for the pres-
ence of sequence information. In particular, we were alert
for the presence of molecular descriptors that might be
useful in cloning the associated genes in the papers
(described below), particularly Mr, pI, and details of the
purification scheme (Table 14). Systematic searches of
PubMed were also performed to ascertain whether publi-
cations other than those cited by IUBMB might contain
relevant sequence and molecular descriptor data. A total
of 331 publications (1.45 papers per orphan) were exam-
ined for additional molecular descriptors that might be
useful in cloning, as described above. Data obtained from
these publications were assembled into a database.
All artifactual orphans (orphans for which sequence infor-
mation was found during the literature review process)
were reported promptly to the Swiss Institute of Bioinfor-
matics, the European Bioinformatics Institute, the
ORENZA database, and the Nomenclature Committee of
the IUBMB for the relevant database entries to be updated.
Data sources and database analyses
The initial searches for presumed orphan activities were
performed using BioWarehouse version 3.0 (SRI Interna-
tional) running under Oracle 10G (Oracle Corporation,
Redwood Shores, California). BioWarehouse is a bioin-
formatics data warehousing environment developed
under the Bio-SPICE program [23].
Identification and ranking of salvageable orphans
Salvageable orphans are orphan activities for which it is
likely that at least one cognate gene can be identified and
confirmed in a practical manner. The extent of this sal-
Publication year of original publications describing orphan activities Figure 4
Publication year of original publications describing orphan activities. The publication date associated with the original 
source articles of all instances of orphans surveyed here is plotted (286 instances of orphans, corresponding to 228 activities), 
based upon the IUBMB record. In a number of cases more than one instance of an orphan activity was evaluated because the 
activity was reported in more than one species.
Distribution of enzymatic activities in validated orphans Figure 3
Distribution of enzymatic activities in validated 
orphans. The percentage of validated orphan activities 
belonging to each EC class is shown.BMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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vageability was determined by ranking validated orphans
according to the likelihood and practicality that at least
one cognate gene can be identified, and that the gene
product can be isolated and demonstrated to catalyze the
enzymatic activity in a practical manner.
Orphans were ranked based on data in the original litera-
ture, combined with the availability of the complete
genome sequences for the species in which an orphan was
first elucidated. The principal ranking factors are (1) clear
identification of the species involved and its ease of
Table 9: Example artifactual orphans
EC No. Enzyme Name Original Species Year Swiss-Prot/
TrEMBL
Acc. No.
Cause of artifact Significance of error; 
importance of orphan 
activity
3.4.21.103 Physarolisin
(a proteinase)
Physarum flavicomum 1982 Q8MZS4 IUBMB entry lists a 2003 
paper describing a gene 
coding for a protein with 
this activity [28]. Sequence 
is in Swiss-Prot but 
ENZYME does not 
reference this sequence.
Lack of database cross-
referencing presumably 
involving the long interval 
between the initial 
characterization of the 
activity and the cloning of 
the gene.
3.5.2.16 Maleimide hydrolase Blastobacter sp. A17p-4 1997 Q93T25 ENZYME and IUBMB 
entries are not referencing 
a Swiss-Prot entry from a 
2002 paper describing the 
cloning of gene coding for 
this [29].
Lack of database cross-
referencing is not 
restricted to older 
orphans.
3.5.1.79 Phthalyl amidase Xanthobacter agilis 1995 N/A The sequence, listed in a 
patent associated with a 
1996 paper by [30] in 
Journal of Molecular Catalysis 
B: Enzymatic are available 
from Entrez, but not from 
TrEMBL. The paper itself is 
not available from PubMed.
Note: though the protein 
sequence is not available 
from the UniProt database, 
the DNA sequence is 
present in the EMBL 
database.
3.1.8.2 Diisopropyl-fluoro-
phosphatase
Alteromonas sp. 1954 Q44238 ENZYME and IUBMB 
entries are not referencing 
a Swiss-Prot entry 
associated with a 1996 
paper describing the 
cloning of a gene coding for 
an enzyme with this activity 
[31].
This enzymatic activity 
detoxifies nerve gas. The 
gene is part of a 
widespread gene family 
with otherwise unknown 
function, with members in 
Homo sapiens.
Table 10: Example artifactual orphans that are  salvageable
EC No. Ranking EC No. Ranking
1.1.1.226 excellent 1.4.1.11 Good
1.1.1.265 excellent 1.4.1.17 Good
1.14.13.58 excellent 1.5.1.21 Good
2.4.1.180 excellent 2.3.1.98 Good
2.8.1.3 excellent 2.6.1.58 Good
3.2.1.112 excellent 2.6.1.75 Good
3.2.1.128 excellent 3.1.3.47 Good
3.5.1.58 excellent 3.1.6.17 Good
3.6.1.18 excellent 3.2.1.100 Good
1.1.1.172 good 3.4.17.16 Good
1.1.1.196 good 3.5.1.30 Good
1.13.12.9 good 3.5.3.2 Good
1.14.13.23 good 4.2.1.43 Good
1.14.16.5 good 4.2.1.62 Good
1.2.1.54 good 5.5.1.11 Good
Validated orphans with a salvageability ranking of "good" or better are listed.BMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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growth; (2) the availability of molecular descriptors, most
importantly the molecular mass (Mr), but also the isoelec-
tric point (pI); (3) the types of purification and analytical
techniques used in the original literature; and (4) evi-
dence that the protein can be purified with reasonable
effort using current techniques, based on factors such as
specific activity, purification yield, number of steps
involved, and availability of substrate and of alternate
purification procedures. "Excellent" and "Good" ratings
indicate an activity associated with a sequenced organism,
and whose purifications and assays are likely to be
straightforward to replicate. "Difficult" activities are those
with tricky purifications or complex assays, but a
sequenced target organism or sequenced related organ-
ism. "Marginal" activities are those for which sequencing
is in progress in the target organism, or a related organism.
"Poor" activities are those for which no genome sequence
is available, or sequencing is in progress in a related
Table 11: Selected salvageable orphans
EC No. Ranking Pathways Activity Species Full 
Genome 
Sequence?
Ongoing 
Genomic 
Sequencing?
Mr (kDa) pI
(pH units)
3.5.1.30 Good None 5-amino-penta-
namidase
Pseudomonas putida 
P2, Pseudomonas 
fluorescens
Yes
(P. putida)*
Several 
Pseudomonas 
species
67 N/A
5.5.1.11 Good None Dichloro-muconate 
cyclo- isomerase
Alcaligenes eutrophus 
JMP 134 (Ralstonia 
eutropha JMP134)
N/A Yes 40 ± 10 N/A
4.2.1.97 Marginal None Phaseollidin 
hydratase
Fusarium solani f.sp. 
Phaseoli
No Different 
species 
(Fusarium 
sporotrichioides)
monomer 1: 
47 monomer 
2: 49
2.3.1.103 Poor None Sinapoylglucose–
sinapoylglucose O-
sinapoyltransferase
Raphanus sativus N/A N/A 55 N/A
A selection of orphans with different salvageability rankings are listed. Pathway names are those used in the MetaCyc database. *: The genomes of 
several strains of P. fluorescens are in the final stages of assembly and are essentially fully sequenced. N/A: not available
Salvageability ranking of validated orphans Figure 5
Salvageability ranking of validated orphans. The suita-
bility of validated orphans for eventual cloning of at least one 
cognate gene was evaluated according to the ranking system 
described in the text. Out of 228 orphans, 57 were judged to 
be salvageable. A: Overall salvageability ranking (percentage 
out of 57); B: Domain distribution of salvageable orphans 
(number of orphans). Note that the total is greater than 57 
because some orphans have different evaluations in the dif-
ferent species in which they have been reported. One 
orphan is also shared between Eubacteria and Eukaryotes.
Distribution of enzymatic activities for salvageable orphans  ranked "good" and "excellent" Figure 6
Distribution of enzymatic activities for salvageable orphans 
ranked "good" and "excellent".BMC Bioinformatics 2007, 8:244 http://www.biomedcentral.com/1471-2105/8/244
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organism, and assay or purification conditions are likely
to be hard to replicate.
Data availability
Information about validated orphan activities has been
entered into the MetaCyc database [27]. Other data gener-
ated by our survey can be found at [9].
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Table 12: Example of artifactual orphans resolved by this survey
EC No. Enzyme Name Species TrEMBL/Swiss-Prot Accession No.
1.1.1.163 Cyclopentanol dehydrogenase Comamonas sp.Q 8 G A V 9
1.13.11.24 Quercetin 2,3-dioxygenase Bacillus subtilis P42106
3.6.3.24 Nickel-transporting ATPase Escherichia coli P33593
2.1.1.143 24-methylenesterol C-methyltransferase Arabidopsis thaliana Q94JS4
2.1.1.143 24-methylenesterol C-methyltransferase Arabidopsis thaliana Q39227
All Swiss-Prot entries listed here have been updated with the corresponding EC number.
Table 13: Main data sources used by the orphan survey
Database name Content Source Accessed via...
TrEMBL [32] Comprehensive protein and DNA 
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Swiss Institute of Bioinformatics Web
Comprehensive Microbial Repository 
(CMR [33])
Extensive genomic data for microbial 
species
The Institute for Genomic Research BioWarehouse
BioCyc databases Collection of pathway/genome 
databases primarily concerned with 
microbial species
Bioinformatics Research Group, SRI 
International
BioWarehouse
IUBMB Enzyme Nomenclature [34] Description of enzymes that have 
been assigned an EC number by the 
Enzyme Commission
Nomenclature Committee of the 
International Union of Biochemistry 
and Molecular Biology
Web and BioWarehouse
ENZYME [35] Repository of information relative to 
the nomenclature of enzymes
Swiss Institute of Bioinformatics Web and BioWarehouse
NCBI Taxonomy [36] Taxonomy database National Center for Biotechnology 
Information
Web and BioWarehouse
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